Identification of novel non-toxic and anti-angiogenic α-fluorinated chalcones as potent colchicine binding site inhibitors-Reference-Cited by-同舟云学术

Identification of novel non-toxic and anti-angiogenic α-fluorinated chalcones as potent colchicine binding site inhibitors

Published:2022-01-03 Issue:1 Volume:37 Page:339-354
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Sun Moran¹²,Yuan Minghua²,Kang Yingying²,Qin Jinling²,Zhang Yixin²,Duan Yongtao¹,Wang Longfei¹,Yao Yongfang¹²³

Affiliation:

1. Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou University, Zhengzhou, China

2. Key Laboratory of Advanced Drug Preparation Technologies, School of Pharmaceutical Sciences, Ministry of Education, Zhengzhou University, Zhengzhou, China;

3. State Key Laboratory of Esophageal Cancer Prevention & Treatment, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2021.2014831

Reference24 articles.

1. Integration of oncology and palliative care: a Lancet Oncology Commission

2. Cancer drug resistance: an evolving paradigm

3. Disrupting tumour blood vessels

4. Disrupting tumour blood vessels

5. Antivascular Actions of Microtubule-Binding Drugs

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of New Thiazole-Privileged Chalcones as Tubulin Polymerization Inhibitors with Potential Anticancer Activities;Pharmaceuticals;2024-08-31

2. Current scenario of chalcone hybrids with antibreast cancer therapeutic applications;Archiv der Pharmazie;2024-01-16

3. Indole derivatives targeting colchicine binding site as potential anticancer agents;Archiv der Pharmazie;2023-07-21

4. Chalcones and Gastrointestinal Cancers: Experimental Evidence;International Journal of Molecular Sciences;2023-03-22

5. Privileged chalcone scaffolds in drug discovery;Privileged Scaffolds in Drug Discovery;2023